Average-Weight Methodology in Weight-Based Unfractionated Heparin Therapy in the Presence of Obesity

Affiliations

¹ MemorialCare Heart & Vascular Institute, Long Beach Memorial, Long Beach, CA; Department of Pharmacy Services, Long Beach Memorial, Long Beach, CA; School of Pharmacy, University of California, San Francisco, CA. Electronic address: msafani@memorialcare.org.
² MemorialCare Heart & Vascular Institute, Long Beach Memorial, Long Beach, CA; School of Medicine, University of California, Irvine, CA.
³ MemorialCare Heart & Vascular Institute, Long Beach Memorial, Long Beach, CA.
⁴ Department of Pharmacy Services, Long Beach Memorial, Long Beach, CA; Skaggs School of Pharmacy, University of California, San Diego, CA.

Comment

Michael Safani et al. Chest. 2017 May.

. 2017 May;151(5):1187-1188.

doi: 10.1016/j.chest.2016.12.016.

¹ MemorialCare Heart & Vascular Institute, Long Beach Memorial, Long Beach, CA; Department of Pharmacy Services, Long Beach Memorial, Long Beach, CA; School of Pharmacy, University of California, San Francisco, CA. Electronic address: msafani@memorialcare.org.
² MemorialCare Heart & Vascular Institute, Long Beach Memorial, Long Beach, CA; School of Medicine, University of California, Irvine, CA.
³ MemorialCare Heart & Vascular Institute, Long Beach Memorial, Long Beach, CA.
⁴ Department of Pharmacy Services, Long Beach Memorial, Long Beach, CA; Skaggs School of Pharmacy, University of California, San Diego, CA.

No abstract available

Comment on

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Kearon C, et al. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7. Chest. 2016. PMID: 26867832